Atlas Trials

The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Clinical trial NCT04747080 · UNKNOWN

Trial details

NCT number
NCT04747080
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
ITPImmune Thrombocytopenia
Start date
2021-03-01
Primary completion
2023-03-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.